COVID-19 | Specialty

The OncLive COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more.

ASCO Calls for Inclusion of Individuals With Cancer on COVID-19 Vaccine Trials

June 23rd 2021

Individuals with cancer or who have a history of cancer should qualify for inclusion on COVID-19 vaccine trials, unless there is a safety justification for exclusion.

Matsen Reflects on Changes to Breast Cancer Surgery During COVID-19

June 21st 2021

Dr. Masten reflects on the main challenges that arose during the COVID-19 lockdown with regard to surgery in patients with breast cancer, the steps that were taken as the lockdown started to lift, and the changes that have been made with regard to managing patients around the time of surgery and in the operating room.

Oncology Leaves Its Mark on 2020 Research and Development Trends

June 16th 2021

Rates of clinical trial initiation, novel drug development, and collaborative research and development deals were oncology.

COVID-19 Vaccination Hesitancy Finds Echo in Cancer Care

June 1st 2021

Although the COVID-19 vaccine rollout is unprecedented in speed and scope, the process of postapproval surveillance has been shown to be robust and should serve as a source of reassurance to the public regarding the effectiveness of the initial and follow-up review process.

Dr. Doroshow on Increasing Patient Accrual to Clinical Trials During the COVID-19 Pandemic

May 26th 2021

James H. Doroshow, MD, discusses strategies that were implemented to increase patient accrual to clinical trials during the COVID-19 pandemic.

Dr. Gallego on the Impact of COVID-19 on Cancer Care in Spain

May 26th 2021

Jose Maria Mazarico Gallego, MD, discusses the impact of the COVID-19 pandemic on cancer care in Spain.

Dr. Marazzi on the Goals of Examining Topotecan in COVID-19 and Cancer

May 25th 2021

Ivan Marazzi, PhD, discusses the goals for examining topotecan as a treatment for patients with COVID-19 and cancer in India and Brazil.

COVID-19 Inspires a New Mantra for Wellness

May 23rd 2021

The COVID-19 pandemic has inspired a new mantra for wellness in the oncology community and beyond.

Dr. Doroshow on the Importance of Modernizing Clinical Trials After COVID-19

May 18th 2021

James H. Doroshow, MD, discusses the importance of modernizing clinical trials in the post–COVID-19 era.

Modernized Clinical Trials Include Diverse Representation, Decentralization, and Real-World Data in Post–COVID-19 Era

May 18th 2021

Silver linings of the COVID-19 pandemic have opened the door for new opportunities for decentralized clinical trials and real-world data in a post–COVID-19 world.

Oncology Has Lessons to Learn From the COVID-19 Pandemic

May 17th 2021

The coronavirus disease 2019 pandemic has forever changed our world. We must remember the heavy societal burden this virus has wrought, including lives lost, the significant and debilitating late effects for survivors, and the mental health crisis for survivors, caregivers, and the general population.

COVID-19 Accommodations May Endure Long After the Pandemic

May 14th 2021

Opinion leaders provide a glimpse into the future of what approaches adopted during COVID-19 may persist in oncology after the pandemic ends.

Dr. Garassino on Safety Protocols for Patients With Cancer in Italy During COVID-19

May 13th 2021

Marina Chiara Garassino, MD, discusses key safety protocols that were initiated for patients with cancer in Italy during the COVID-19 pandemic.

Reaching Conclusions From Limited Data Holds Pitfalls

May 13th 2021

The challenges of assessing COVID-19 vaccines shows that events in the real world may differ from those of a formal objective scientific analysis, especially in a setting where such evaluations of necessity involve very small numbers.

Dr. Lavery on the Decline in Esophageal Cancer Diagnoses in Ireland During COVID-19

May 11th 2021

Anita Lavery, MD, MRCP, discusses the decline in esophageal cancer diagnoses in Ireland during the COVID-19 pandemic.

Clinical Trial Diversity Efforts Gain Steam

May 4th 2021

Nearly 30 years after National Institutes of Health sought to increase participation of minorities in clinical trials, a demographic imbalance remains.

COVID-19 Has Diverse Effects on Cancer Care

May 3rd 2021

OncologyLive® Advisory Board members speak about how COVID-19 has touched all aspects of oncology practice, research, and treatment.

Missteps Highlight the Need for Objectivity in Science

April 30th 2021

Although the spectacular success associated with the development of several safe and highly efficacious vaccines and therapies for COVID-19 has once again confirmed the remarkable impact of advancements on public and individual health, we must also acknowledge recent stunning examples of the failure of scientifically oriented government agencies to provide objectively valid nonpolitical recommendations, policies, and conclusions.

Dr. Fleury on the Advancement of Decentralized Clinical Trials During COVID-19

April 29th 2021

Mark Fleury, PhD, discusses the advancement of decentralized clinical trials during the COVID-19 pandemic.

Dr. Davies on Managing Melanoma During the COVID-19 Pandemic

April 28th 2021

Michael A. Davies, MD, PhD, discusses the management of patients with melanoma during the COVID-19 pandemic.